9-[4-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl]-2-quinolin-2-yl-[1]benzothiolo[3,2-b]pyridine
C41H25N5S — CID 168747123
Data last refreshed: (MolForge compound catalog, from PubChem)
About 9-[4-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl]-2-quinolin-2-yl-[1]benzothiolo[3,2-b]pyridine
9-[4-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl]-2-quinolin-2-yl-[1]benzothiolo[3,2-b]pyridine (PubChem CID 168747123) has the molecular formula C41H25N5S and a molecular weight of 619.75 g/mol. Its IUPAC name is 9-[4-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl]-2-quinolin-2-yl-[1]benzothiolo[3,2-b]pyridine.
Molecular Properties
| Compound Name | 9-[4-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl]-2-quinolin-2-yl-[1]benzothiolo[3,2-b]pyridine |
|---|---|
| PubChem CID | 168747123 |
| Molecular Formula | C41H25N5S |
| Molecular Weight | 619.75 g/mol |
| Exact Mass | 619.18 |
| IUPAC Name | 9-[4-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl]-2-quinolin-2-yl-[1]benzothiolo[3,2-b]pyridine |
| SMILES | c1ccc(-c2nc(-c3ccccc3)nc(-c3ccc(-c4cccc5sc6ccc(-c7ccc8ccccc8n7)nc6c45)cc3)n2)cc1 |
| InChI | InChI=1S/C41H25N5S/c1-3-11-28(12-4-1)39-44-40(29-13-5-2-6-14-29)46-41(45-39)30-20-18-26(19-21-30)31-15-9-17-35-37(31)38-36(47-35)25-24-34(43-38)33-23-22-27-10-7-8-16-32(27)42-33/h1-25H |
| InChIKey | HJBOEBHQJRYRCG-UHFFFAOYSA-N |
| XLogP | 10.52 |
| TPSA | 64.45 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 47 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 619.75 |
| LogP ≤ 5 | 10.52 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 168747123 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.